TP53 and cancer: Not all P53 mutants increase glycolysis (32) and wild-type P53 can promote the metabolic switch from oxidative phosphorylation to glycolysis by inducing p53 upregulated modulator of apoptosis (PUMA)-mediated disruption of mitochondrial pyruvate uptake in cancer cells (33).